What are the financial numbers? Not interested in test results and other fluff, more interested to see what they are selling from their current product range.
Printable View
That maybe true Sparky, but posting a picture of a large building tells me nothing as an investor. Do they own the building and was it prudent to spend money on this over their obvoius need for sales and marketing attention... or are they refitting 2 rooms/floors etc? What was the capital outlay and ROI?
Since there are three of them and are obvious superstars, it interests me why they chose PEB over other obvious companies that would love to have them due to their impressive achievements.
I see alot of companies fail in the USA and this is because they cant sell. I hope they are an exception.
A little patience will be rewarded Schrodinger.
We are all genuinely interested in seeing PEB prosper, and it should be an interesting watch over the next three months leading up to PEB's first half year report on US sales.
The share market leads sales performance and reacts if that performance does not unfold. We should start to see the market beginning to back the company now and build in some anticipation of an adequate HY14 sales report.
With five years of growth ahead, it's all up from here.
I'm pretty sure it's been mentioned in one of their previous reports that they are one of the people leasing space in that building.
Also it's at the Hershey Research Center amongst numerous other medical companies. Interestingly (to me at least) Jack Atchason who is listed as Director of Strategic Accounts for PEDUSA is actually Executive Director at the Hershey Research Center so while working at PEDUSA isn't his only job he's going to have some pretty solid contacts in the industry and hopefully experience with other companies in PEDUSAs situation. I'd say the fact he chose PEB over "other obvious companies" shows he thinks they have a good shot at success.
The presentation that was given at the agm was perfectly adequate to me. Sure it was'nt some slick glossy piece of spin put out by a comminications division or PR firm, but I've seen plenty of those over the years and I know which I would rather have.
The amount of floor space leased in the Hershey building, the cost of the fitout, potential additional space has all been previously disclosed by Pacific Edge.
I find it heartening reading through the history of the ASX listed Prana Bio (pbt) and seeing the positive differences and same strengths as that of PEB. While the products that companies provide are totally different I do get the feeling that PEB have truly cracked the large hurdles of commercialisation and positive clinical trials. To me this provides the company with a tangible way forward which we are about to start seeing.PEB certainly have kept their cards close to their chest which for me is only strengthening my support.
Todays NBR has an article on Pacific Edge in their Margin Call column written by David Williams.
It does'nt appear to be available online but its hardcopy edition is probably worth a read, although there is nothing particularly new being revealed.
It mentions the recently completed DHB user programmes, Canterbury and Waitemata, and that David Darling has met with Tony Ryall this week for the second time. Also mentions a customer in the US who is about to embark on the user programme and whose size is roughly three times the size of all the NZ health boards combined.
Fantastic news thanks Barney, I'm off to buy a copy.
Hopefully a market announcement will soon follow, they would seem to be market appropriate announcements given PEB's stage in business.
Isn't the market in NZ about 15k tests a year? 3 times this is 45k tests... jeez if PEB pull that one off it will be a massive coup! At that rate they would move their books from being in the red to black and some!
and the Intrinsic Value would be around $3.00 IF it happens
using Johnny the Horses post from way back which had a table that indicated (45000tests x $550.00)
=$24750000 revenue would give an IV above 3.00. I believe this table was constructed from the projected 5 year plan. As far as I'm aware this hasn't been called to task so far.
Sounds good. Any indications of insider trading on the market?
Well, unless the seller of 50k or 100 k each and every open and close since last week is an insider, no.....
User programmes are great and essential to sales but lets not get too excited yet. The programmes can run for extended periods. I'd like to see multiple potential clients before throwing a party.
Lol, yes I thought you already knew the answer Schrodinger.....:t_up: